Through a comprehensive analysis of the complex relationship between IL-17 and COPD pathogenesis, novel therapeutic avenues can be explored, potentially transforming the approach to managing this incapacitating condition. The gene discussed is IL17A; the disease is chronic obstructive pulmonary disease.